AQQRF (Aquarius Surgical Technologies) OCF Margin %: -64.71% (As of Dec. 2025)


What is Aquarius Surgical Technologies OCF Margin %?

Aquarius Surgical Technologies AQQRF OCF Margin % is -64.71% as of Dec. 2025. The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Aquarius Surgical Technologies ranks worse than 89.57% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Aquarius Surgical Technologies's Cash Flow from Operations for the three months ended in Dec. 2025 was $-0.01 Mil. Aquarius Surgical Technologies's Revenue for the three months ended in Dec. 2025 was $0.02 Mil. Therefore, Aquarius Surgical Technologies's OCF Margin % for the quarter that ended in Dec. 2025 was -64.71%.

As of today, Aquarius Surgical Technologies's current OCF Yield % is -63.04%.

The historical rank and industry rank for Aquarius Surgical Technologies's OCF Margin % or its related term are showing as below:

AQQRF' s OCF Margin % Range Over the Past 10 Years
Min: -5416.67   Med: -123.41   Max: 19.12
Current: -227.27

During the past 13 years, the highest OCF Margin % of Aquarius Surgical Technologies was 19.12%. The lowest was -5416.67%. And the median was -123.41%.

AQQRF's OCF Margin % is ranked worse than
89.57% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: 5.86 vs AQQRF: -227.27

Aquarius Surgical Technologies OCF Margin % Related Terms

Aquarius Surgical Technologies OCF Margin % Historical Data

* Premium members only.

The historical data trend for Aquarius Surgical Technologies's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aquarius Surgical Technologies OCF Margin % Chart

Aquarius Surgical Technologies Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -77.37 -33.98 19.46 -123.84 -423.81

Aquarius Surgical Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,244.44 -436.36 -238.46 -250.00 -64.71

AQQRF vs ABT, SYK, MDT: OCF Margin % Comparison

For the Medical Devices subindustry, Aquarius Surgical Technologies's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquarius Surgical Technologies OCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aquarius Surgical Technologies's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Aquarius Surgical Technologies's OCF Margin % falls into.


Aquarius Surgical Technologies OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Aquarius Surgical Technologies's OCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-0.267/0.063
=-423.81 %

Aquarius Surgical Technologies's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.011/0.017
=-64.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -64.71% mean?
Aquarius Surgical Technologies (AQQRF) has a OCF Margin % of -64.71% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aquarius Surgical Technologies and its competitors. According to the industry distribution chart, Aquarius Surgical Technologies ranks #730 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 89.6%.
Is Aquarius Surgical Technologies' OCF Margin % too high?
Aquarius Surgical Technologies' current OCF Margin % is -64.71%. Based on the distribution chart, Aquarius Surgical Technologies ranks #730 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Aquarius Surgical Technologies' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aquarius Surgical Technologies ranks #730 out of 815 companies for OCF Margin %. This places Aquarius Surgical Technologies in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Aquarius Surgical Technologies and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aquarius Surgical Technologies's current OCF Margin % is -64.71%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aquarius Surgical Technologies stock overvalued right now?
Aquarius Surgical Technologies (AQQRF) has a current OCF Margin % of -64.71%. The current OCF Margin % is -64.71%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Aquarius Surgical Technologies (AQQRF), the current OCF Margin % is -64.71% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aquarius Surgical Technologies Business Description

Other Exchanges ASTI:Canada
Address 89 Scollard Street, Toronto, ON, CAN, M5R 1G4
Aquarius Surgical Technologies Inc is engaged in the development, sale, distribution, marketing, and exploitation of laser-driven technologies for use in surgical environments. Through its subsidiary, the company operates as an international distributor, service, and support organization providing integrated laser-based solutions across multiple medical disciplines. These disciplines include urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, many of which are now considered the standard of care for treatment. Geographically, the company generates maximum revenue from the sale of medical devices in the United States, and also has its presence in Canada.